LCM
LFCR icon

Laurion Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Laurion Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-38,773
Closed -$199K – 466
2024
Q2 		$199K Sell
38,773
-92,810
-71% -$550K ﹤0.01% 480
2024
Q1 		$699K Hold
131,583
– – 0.01% 408
2023
Q4 		$814K Buy
+131,583
New +$914K 0.01% 358
2023
Q3 		– Sell
-14,405
Closed -$139K – 582
2023
Q2 		$139K Buy
+14,405
New +$88K ﹤0.01% 500

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Laurion Capital Management's LFCR Position: Q3 2024 in Review

Laurion Capital Management sold out of Lifecore Biomedical (LFCR) in Q3 2024, closing a stake of 38,773 shares — an estimated $199K sold.

Laurion Capital Management first reported a position in LFCR in Q2 2023 and held it in 4 quarters. The position peaked at $814K in Q4 2023. 82 funds tracked by Wall St. Rank hold LFCR as of Q3 2024.

  • Laurion Capital Management reported no remaining Lifecore Biomedical position as of Q3 2024 after selling out during the quarter.
  • Laurion Capital Management sold 38,773 Lifecore Biomedical shares in Q3 2024, an estimated $199K.
  • Laurion Capital Management first reported a position in Lifecore Biomedical in Q2 2023 and held it in 4 quarters.
  • Laurion Capital Management's Lifecore Biomedical position peaked at $814K in Q4 2023.
  • 82 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2024.

Based on Laurion Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.